Dr. Farshchian : The knee joint is now being treated with regenerative medicine at he center for regenerative medicine

(PRWEB) January 03, 2013

"The knee joint is now being treated with regenerative medicine at he center for regenerative medicine." according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center for regenerative medicine.
A major synptom of Arthritis of the knee is known as "Crepitus," a medical term describing grating, crackling or popping sounds. They can be accompanied by internally-experienced sensations of a scraping-like movement between joints beneath the skin surface.
Crepitus can be created when two rough surfaces of the joints come into direct contact with each other, most commonly caused in the knee by the decrease or total absence of cushioning material between coordinating elements, like the femur and tibia
The resulting noise and sensation are often experienced in the early stages of Osteoarthritis of the knee, and are normally due to a deterioration or absence of cartilage and meniscus in the knee joint structure.
U.S.A. based physician, Dr. Farshchian, is a medical author, humanitarian, and active republican member. He is best known for coining the term "orthopedic regenerative medicine." Dr. Farshchian is recognized as a leading authority in the new clinical science of regenerative medicine. He is also a Television personality, currently hosting "The Arthritis Show."
The Center for Regenerative Medicine in Miami, Florida concentrates on helping arthritic and injured people to get back to a functional level of life and their activities using non-surgical techniques and Orthopedic medicine. The center's expertise is in treatment of conditions of spine, knees, shoulders and other cartilage damages. They have developed non-surgical and rehabilitation techniques focused on treatment and management of joint pain. Their team includes health professionals organized around a central theme. Their website is http://www.arthritisusa.net

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10217789.htm